CEI
INDV icon

Clark Estates Inc’s Indivior Pharmaceuticals INDV Stock Holding History

Clark Estates Inc’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.79M Hold
92,300
– – 0.87% 19
2026
Q1 		$2.81M Hold
92,300
– – 0.68% 23
2025
Q4 		$3.31M Sell
92,300
-61,300
-40% -$1.87M 0.8% 17
2025
Q3 		$3.7M Sell
153,600
-50,000
-25% -$1.05M 0.85% 20
2025
Q2 		$3M Buy
203,600
+17,325
+9% +$202K 0.67% 17
2025
Q1 		$1.78M Sell
186,275
-71,125
-28% -$748K 0.38% 61
2024
Q4 		$3.2M Buy
257,400
+3,300
+1% +$33.9K 0.62% 32
2024
Q3 		$2.48M Buy
+254,100
New +$2.98M 0.46% 72

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clark Estates Inc's INDV Position: Q2 2026 in Review

Clark Estates Inc held its Indivior Pharmaceuticals (INDV) position steady in Q2 2026 at 92,300 shares worth $3.79M. The position accounts for 0.87% of the portfolio, ranked #19.

Clark Estates Inc first reported a position in INDV in Q3 2024 and has held it in 8 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Clark Estates Inc held 92,300 shares of Indivior Pharmaceuticals worth $3.79M as of Q2 2026.
  • Clark Estates Inc left its Indivior Pharmaceuticals share count unchanged in Q2 2026.
  • Indivior Pharmaceuticals made up 0.87% of Clark Estates Inc's portfolio in Q2 2026, its #19 holding.
  • Clark Estates Inc first reported a position in Indivior Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.